Impact of CES1 Genotype on Remimazolam
Clinical trial NCT05841667 · RECRUITING
Trial details
- NCT number
- NCT05841667
- Sponsor
- Korea University Guro Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-06
- Primary completion
- 2025-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.